HK inno.N made an announcement on Aug. 26 that it will use artificial skin that is implemented with a 3D printer to develop treatments for skin diseases.
HK inno.N is planning to conduct related research by cooperating with T&R Biofab, which has 3D printing artificial skin technology. Artificial skin, which is made with a 3D printer, is drawing attention as a technology that will replace animal testing.
HK inno.N has decided to verify its efficacy by applying candidate materials for autoimmune diseases and skin diseases, which are currently being developed, to 3D printed artificial skin that is manufactured by T&R Biofab.
In order to start research in earnest, HK inno.N signed a memorandum of understanding (MOU) with T&R Biofab on Aug. 25 on R&D cooperation on "evaluation of drugs and functional materials using 3D bioprinting artificial skin."
With this MOU, T&R Biofab plans to develop 3D printed artificial skin that meets HK inno.N's needs, while HK inno.N plans to apply new drug substances for autoimmune diseases and skin diseases that are currently being developed to 3D artificial skin to verify their effectiveness.
T&R Biofab's 3D printed artificial skin is implemented with a 3D printer that realizes structures and functions similar to actual skin, and it is possible to measure skin elasticity, aging index, and protein expression.
"We will not only use artificial skin to verify the efficacy of medicines for skin diseases, but we will also conduct active research between the two companies so that it can be applied to research on health functional foods and cosmetics materials," said Koh Dong-hyun, head of the HK inno.N Research Institute.
kslee@koreaittimes.com
